GEISINGER WYOMING VALLEY MED CTR — History
CCN 390270 | 3-year financial timeline | COVID resilience: 53/100
🛡️ Public data only — no PHI permitted on this instance.
$783M
Latest Revenue (FY2022)
+8.5%
Revenue CAGR (3yr)
5.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $665M | $717M | $783M | +9.1% | +8.5% |
| Operating Expenses | $585M | $658M | $736M | +11.9% | +12.2% |
| Operating Margin | 12.1% | 8.3% | 5.9% | -28.4% | -29.8% |
| Net Income | $80M | $60M | $47M | -21.9% | -23.8% |
| Licensed Beds | 300 | 318 | 309 | -2.8% | +1.5% |
| Total Patient Days | 81,701 | 91,747 | 91,392 | -0.4% | +5.8% |
| Medicare Day % | 29% | 28% | 28% | -0.1% | -2.9% |
| Medicaid Day % | 3% | 6% | 3% | -47.2% | -3.8% |
COVID Impact & Recovery
Resilience Score: 53/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +17.7% ($665M → $783M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.5%
This Hospital
+7.6%
State Avg
Latest Margin
5.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $842M | 2.9% |
| FY2024 (proj) | $901M | -0.2% |
| FY2025 (proj) | $960M | -3.2% |